Linda Hanssens
Linda Hanssens is an expert in Psychiatry at Miltenyi Biomedicine GmbH (Germany). Linda Hanssens has authored 90 publications, the most recent in 2026. SLR score: 191 (community average: 125). How the SLR is computed.
LeadR Profile
Psychiatry
Subspecialties: Hematology - Biochemistry - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 90
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial. PMID 42045577 — arterial pressure, genes, fms, pilots, safety, parturition, blood component removal, pre-eclampsia, birth weight, protein-tyrosine kinases, tyrosine, vascular endothelial growth factor receptor-1 | Nat Med Top journal | 2026 | 0 |
| Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases. PMID 41644747 — cells, molecular biology, autoimmune diseases, therapeutics, child, car-t cell | Nat Med Top journal | 2026 | 0 |
| Zamtocabtagene Autoleucel in Relapsed/refractory B-NHL: 5-year Follow Up of a CD20/19 tandem CAR T Cell Phase 1 Trial. PMID 41512222 — cells, therapeutics, t-lymphocytes, hematologic diseases, car-t cell | Blood Adv | 2026 | 0 |
| CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial. PMID 41501497 — cells, safety, autoimmune diseases, therapeutics, car-t cell | Nat Med Top journal | 2026 | 0 |
| Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse. PMID 40558311 — cells, point-of-care systems, therapeutics, hematologic diseases, car-t cell | Blood Adv | 2025 | 0 |
LeadR Networks
Main global connection map